Life Science Reit Stock Current Valuation
| LABS Stock | 45.60 2.20 5.07% |
Valuation analysis of Life Science REIT helps investors to measure Life Science's intrinsic value by examining its available valuation indicators, including the cash flow records, the balance sheet account changes and income statement patterns.
Overvalued
Today
Please note that Life Science's price fluctuation is very steady at this time. Calculation of the real value of Life Science REIT is based on 3 months time horizon. Increasing Life Science's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Life stock is determined by what a typical buyer is willing to pay for full or partial control of Life Science REIT. Since Life Science is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Life Stock. However, Life Science's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 45.6 | Real 35.62 | Hype 45.6 | Naive 51.61 |
The intrinsic value of Life Science's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Life Science's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Life Science REIT helps investors to forecast how Life stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Life Science more accurately as focusing exclusively on Life Science's fundamentals will not take into account other important factors: Life Science REIT Company Current Valuation Analysis
Life Science's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current Life Science Current Valuation | 256.44 M |
Most of Life Science's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Life Science REIT is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, Life Science REIT has a Current Valuation of 256.44 M. This is 98.31% lower than that of the Diversified REITs sector and significantly higher than that of the Real Estate industry. The current valuation for all United Kingdom stocks is 98.46% higher than that of the company.
Life Current Valuation Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Life Science's direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Life Science could also be used in its relative valuation, which is a method of valuing Life Science by comparing valuation metrics of similar companies.Life Science is currently under evaluation in current valuation category among its peers.
Life Fundamentals
| Return On Equity | -0.14 | |||
| Return On Asset | 0.014 | |||
| Profit Margin | (1.99) % | |||
| Operating Margin | 0.50 % | |||
| Current Valuation | 256.44 M | |||
| Shares Outstanding | 350 M | |||
| Shares Owned By Insiders | 10.51 % | |||
| Shares Owned By Institutions | 81.72 % | |||
| Price To Book | 0.57 X | |||
| Price To Sales | 7.95 X | |||
| Revenue | 19.94 M | |||
| Gross Profit | 14.51 M | |||
| EBITDA | 8.72 M | |||
| Net Income | (21.71 M) | |||
| Total Debt | 107.92 M | |||
| Book Value Per Share | 0.76 X | |||
| Cash Flow From Operations | 7.62 M | |||
| Earnings Per Share | (0.11) X | |||
| Target Price | 37.0 | |||
| Beta | -0.034 | |||
| Market Capitalization | 159.97 M | |||
| Total Asset | 410.7 M | |||
| Retained Earnings | (41.58 M) | |||
| Annual Yield | 0.05 % | |||
| Net Asset | 410.7 M | |||
| Last Dividend Paid | 0.02 |
About Life Science Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Life Science REIT's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Life Science using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Life Science REIT based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Life Stock Analysis
When running Life Science's price analysis, check to measure Life Science's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Life Science is operating at the current time. Most of Life Science's value examination focuses on studying past and present price action to predict the probability of Life Science's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Life Science's price. Additionally, you may evaluate how the addition of Life Science to your portfolios can decrease your overall portfolio volatility.